# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Exane BNP Paribas analyst James Picariello upgrades Adient (NYSE:ADNT) from Underperform to Neutral and announces $26 price ...
Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $33 to $32.
Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and lowers the price target from $35 to $32.
Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $37 to $34.
Deutsche Bank analyst Emmanuel Rosner maintains Adient (NYSE:ADNT) with a Hold and lowers the price target from $32 to $30.
Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $38 to $33.